CompletedPhase 2NCT01488409

Effects of Acipimox on Mitochondrial Function in Obesity

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Massachusetts General Hospital
Principal Investigator
Steven Grinspoon, MD
Massachusetts General Hospital
Intervention
Acipimox(drug)
Enrollment
39 target
Eligibility
18-55 years · All sexes
Timeline
20122015

Study locations (1)

Collaborators

American Diabetes Association

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01488409 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials